Page 31 - தேடலை பரிசோதனை இணைக்கப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. The global genetic counseling market was valued at $972.2 million in 2019 and is anticipated to grow over $4,079.3 million by 2030. The pharmacogenomic genetic counseling segment is expected to witness a robust CAGR of 17.39% during the forecast period, 2020-2030. GeneDX and InformedDNA are currently the largest shareholders in the global genetic counseling market. This market dominance is attributed to the company s presence within the market through its expansive service portfolio, led by dedicated genetic counselors workforce that provides services in prenatal/preconception, pediatric, indication risk assessment, and pharmacogenomic counseling and other genetic counseling services.

United statesLaura woodQuest diagnostics incorporatedResearch analysisInvitae corporationType of serviceLevel of serviceGenpath diagnostics an opko health companyGenetics laboratory corporation of americaCustom researchOpko health companyLaboratory corporation of americaBiron health groupOffice hours callReimbursement among major insurance providersCompany profiles